New Statins (Cholesterol & Cardio) treatments in trials

Atorvastatin, Rosuvastatin, Simvastatin — lipid-lowering & cholesterol control. Track the treatments still in clinical testing and see which are closest to an FDA decision.

16Closest to approval (Phase 3)

18Mid-stage (Phase 2)

9Early stage (Phase 1)

142Total recruiting

In one line

142 statins (cholesterol & cardio) trials are recruiting right now, 16 of them in Phase 3 — the stage immediately before an FDA decision.

Recruiting now

Twelve of the currently recruiting studies. Open one for a plain-English summary of who it is for and what it involves.

NCT06206759RecruitingVitamin C Administration and Triglycerides Level in Critical Care PatientsSponsorMeir Medical CenterEnrolling2,000Summary NCT06501443Phase 4RecruitingLATAM LOWERS LDL-CSponsorNovartis PharmaceuticalsEnrolling520Summary NCT07578090RecruitingRegional Innovation in Chronic Disease and Elderly CareSponsorFu Jen Catholic UniversityEnrolling1,000Summary NCT06615609NARecruiting"Smart Family Doctor" Assisted Comprehensive Management of Secondary Prevention Among Post Coronary Artery Bypass Graft Patients or Post Percutaneous Coronary Intervention PatientsSponsorChina National Center for Cardiovascular DiseasesEnrolling536Summary NCT06125847EARLY_Phase 1RecruitingNGGT006 Gene Therapy for Homozygous Familial HypercholesterolemiaSponsorFirst Affiliated Hospital Xi'an Jiaotong UniversityEnrolling21Summary NCT06966258NARecruitingInspire HER: Inspiring the Heart and Emotions for Radical HealthSponsorUniversity of Alabama at BirminghamEnrolling90Summary NCT05430828RecruitingEvaluation of Adherence, Persistence and Efficacy of Treatment With PCSK9 Inhibitors in ItalySponsorFederico II UniversityEnrolling5,000Summary NCT06164730Phase 1RecruitingA Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery DiseaseSponsorVerve Therapeutics, Inc.Enrolling85Summary NCT05176132RecruitingSouth Danish Obesity Initiative, Screening for Unrecognized Obesity Related DiseaseSponsorClaus Bogh JuhlEnrolling2,700Summary NCT04485871NARecruitingTargeting Risk Factors for Diabetes in Subjects With Normal Blood Cholesterol Using Omega-3 Fatty AcidsSponsorInstitut de Recherches Cliniques de MontrealEnrolling48Summary NCT05242055RecruitingIntegrated Diagnosis and Treatment of CKD on OutcomesSponsorCapital Medical UniversityEnrolling1,000Summary NCT02009345RecruitingFamilial Hypercholesterolemia Canada / Hypercholesterolemie Familiale CanadaSponsorMcGill University Health Centre/Research Institute of the McGill University Health CentreEnrolling6,000Summary

View all 142 on ClinicalTrials.gov

Already approved for this area

HMG-CoA Reductase Inhibitors (Statins)

Lipitor, Crestor, Zocor, Pravachol — approved products with their NDC records and billing codes.

Open the class

Every NDC in this class

The FDA registry filtered to hmg-coa reductase inhibitors (statins), with packaging and 11-digit billing conversions.

Search the directory

Loading the trial explorer…